Influence of Microbiota on NSAID Enteropathy: A Systematic Review of Current Knowledge and the Role of Probiotics

被引:0
作者
Martina Rekatsina
Antonella Paladini
Maria Grazia Cifone
Francesca Lombardi
Joseph V. Pergolizzi
Giustino Varrassi
机构
[1] Moorfields Eye Hospital,Anaesthetic Department
[2] University of L’Aquila,Department of Life, Health and Environmental Sciences
[3] NEMA Research Group,undefined
[4] Inc,undefined
[5] Paolo Procacci Foundation,undefined
[6] World Institute of Pain,undefined
来源
Advances in Therapy | 2020年 / 37卷
关键词
Enteropathy; Gut microbiota; NSAIDs; Probiotics;
D O I
暂无
中图分类号
学科分类号
摘要
Microbiota are increasingly studied, providing more precise information on their important role in physiologic processes. They also influence some pathologic processes, such as NSAID-induced enteropathy. This side effect is much more diffuse than it has been described in the past. It derives mainly from the local action of the medicines and is caused by the local binding of gram-negative bacterial lipopolysaccharides and infiltration of neutrophils into the intestinal mucosa. The initial interest in the interaction between these damages and microbiota is very old, but new and interesting data are available. This review aims to focus on recent studies on NSAID-induced enteropathy, an often-underestimated medical condition, and on the influence of microbiota on this condition. Apart from the broadly investigated use of antibiotics and other mucosal protective solutions, this systematic review focuses mostly on the use of probiotics, which directly influence intestinal microflora. Other important factors influencing NSAID-induced enteropathy, such as sex, advanced age, infection and use of proton pump inhibitors, are also discussed.
引用
收藏
页码:1933 / 1945
页数:12
相关论文
共 303 条
  • [1] Blackler RW(2015)Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota Br J Pharmacol 172 992-1004
  • [2] Motta JP(1977)Resistance of germfree rats to indomethacin-induced intestinal lesions Prostaglandins 14 333-341
  • [3] Manko A(2013)NSAID enteropathy: could probiotics prevent it? J Gastroenterol 48 689-697
  • [4] Workentine M(2017)Microbiota plays a key role in non-steroidal anti-inflammatory drug-induced small intestinal damage Digestion 95 22-28
  • [5] Bercik P(2015)Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID Am J Physiol Gastrointest Liver Physiol 308 994-1003
  • [6] Surette MG(2014)Environmental and NSAID-enteropathy: dysbiosis as a common factor Curr Gastroenterol Rep 16 377-1054
  • [7] Robert A(2014)Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats J Crohns Colitis 8 1043-3539
  • [8] Asano T(2018)Pathophysiology of NSAID-associated intestinal lesions in the rat: luminal bacteria and mucosal inflammation as targets for prevention Front Pharmacol 9 1340-206
  • [9] Montalto M(2017)VSL#3 probiotic differently influences IEC-6 intestinal epithelial cell status and function J Cell Physiol 232 3530-982.e3
  • [10] Gallo A(2019)The epithelial barrier model shows that the properties of VSL#3 depend from where it is manufactured Endocr Metab Immune Disord Drug Targets 19 199-393